In a release on
"Generating a profit this quarter is a positive sign after losses in three consecutive quarters," stated
"Due to uncertainty associated with healthcare reform in
To offset these challenges, management of the company has undertaken a multi-faceted approach to expand distribution channels by adding several new dealers and sales representatives, introduce the new Dynatron ThermoStim Probe, and reduce operating costs over the past two years by more than
The new ThermoStim Probe is a handheld electrode capable of delivering hot or cold therapy in combination with electrical stimulation. It is also designed to allow the practitioner to simultaneously apply soft-tissue mobilization techniques in conjunction with the thermal therapy and electrical stimulation. "Initial feedback from the field regarding this new product has been very encouraging," reported
Because the probe is operated from the control console of the SolarisPlus units, demand for the company's SolarisPlus units is increasing. "We anticipate that the probe will be the catalyst to not only boost sales of our most profitable products, but also attract new distributors to our products," added Beardall.
"The new ThermoStim Probe is a unique product. There is nothing like it on the market. We have applied for patent protection of this proprietary technology. The introduction of this exciting new product, together with the expansion of our distribution channel and cost reduction program, will be the keys to improving the company's operating performance," Cullimore concluded.
((Comments on this story may be sent to firstname.lastname@example.org))
In a release on